Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B Lymphocyte Receptor”

395 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 395 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06777264
What this trial is testing

Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1

Who this might be right for
Acute Lymphoblastic LeukemiaB Cell ALL
First Affiliated Hospital of Zhejiang University 20
Early research (Phase 1)Not Yet RecruitingNCT07335328
What this trial is testing

Fully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell Malignancies

Who this might be right for
B-cell Non Hodgkin Lymphoma
Medical College of Wisconsin 24
Early research (Phase 1)Looking for participantsNCT06875063
What this trial is testing

GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL

Who this might be right for
Non-hodgkin LymphomaRefractory LymphomaChimeric Antigen Receptor T-cell
The First Affiliated Hospital of Xiamen University 45
Very early researchLooking for participantsNCT06792799
What this trial is testing

Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus ErthematosusMulti-Drug Resistant Nephrotic Syndrome+1 more
The Children's Hospital of Zhejiang University School of Medicine 36
Testing effectiveness (Phase 2)Looking for participantsNCT07473167
What this trial is testing

Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients

Who this might be right for
Relapsed Large B-cell LymphomaRefractory Large B-cell LymphomaDiffuse Large B-cell Lymphoma (DLBCL)+3 more
TICAROS Co., Ltd. 98
Early research (Phase 1)Looking for participantsNCT05388695
What this trial is testing

To Observe the Dual-target Chimeric Antigen Receptor T Cells in the Treatment of B Cell Hematologic Tumors

Who this might be right for
19 and 22+ B Cell Hematologic Tumors19 and 20+ B Cell Hematologic Tumors
Hebei Senlang Biotechnology Inc., Ltd. 100
Testing effectiveness (Phase 2)Looking for participantsNCT05869279
What this trial is testing

Allogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic Leukemia

Who this might be right for
B-cell NHLCLL
Fondazione Matilde Tettamanti Menotti De Marchi Onlus 29
Not applicableLooking for participantsNCT06866873
What this trial is testing

CD-19 CAR-T Cell for Pediatric ALL or Lymphoma

Who this might be right for
Lymphoma, B-CellAcute Lymphoblastic Leukemia, Pediatric
Hong Kong Children's Hospital 18
Not applicableUnknownNCT06142175
What this trial is testing

Relmacabtagene Autoleucel in Patients With LBCL

Who this might be right for
Large B-cell Lymphoma
Shanghai Ming Ju Biotechnology Co., Ltd. 200
Testing effectiveness (Phase 2)Study completedNCT03088878
What this trial is testing

Cirmtuzumab and Ibrutinib in Patients With B-Cell Lymphoid Malignancies

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaMantle Cell Lymphoma+1 more
Oncternal Therapeutics, Inc 95
Testing effectiveness (Phase 2)UnknownNCT05651100
What this trial is testing

Safety and Efficacy of Sequential CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Lymphoma

Who this might be right for
Lymphoma, B-Cell
Kecellitics Biotech Company Ltd 50
Testing effectiveness (Phase 2)UnknownNCT02081937
What this trial is testing

CART-19 Immunotherapy in Mantle Cell Lymphoma

Who this might be right for
Hematopoietic/Lymphoid CancerNon-hodgkin Lymphoma,B CellMantle Cell Lymphoma
Chinese PLA General Hospital 2
Early research (Phase 1)Study completedNCT05182073
What this trial is testing

FT576 in Subjects With Multiple Myeloma

Who this might be right for
Multiple MyelomaMyeloma
Fate Therapeutics 31
Early research (Phase 1)UnknownNCT05349266
What this trial is testing

Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B-NHL After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy

Who this might be right for
Non-Hodgkin's Lymphoma
Zhejiang University 16
Testing effectiveness (Phase 2)Looking for participantsNCT06589089
What this trial is testing

Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 18
Testing effectiveness (Phase 2)Ended earlyNCT02488512
What this trial is testing

Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell Lymphomas

Who this might be right for
DLBCLMCLRecurrent Disease
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 1
Not applicableUnknownNCT03794115
What this trial is testing

Immune Repertoire of Ovarian HGSC

Who this might be right for
Ovarian High Grade Serous CarcinomaImmune RepertoireT Lymphocyte Receptor+1 more
Lei Li 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07421167
What this trial is testing

Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)Primary Evans Syndrome (ES)
Novartis Pharmaceuticals 164
Testing effectiveness (Phase 2)Study completedNCT03792633
What this trial is testing

Study of huCART19 for Very High-Risk (VHR) Subsets of Pediatric B-ALL

Who this might be right for
Acute Lymphoblastic Leukemia
University of Pennsylvania 106
Early research (Phase 1)Looking for participantsNCT06313957
What this trial is testing

LUCAR-20SP in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Relapsed B-cell Non-Hodgkin LymphomaRefractory B-cell Non-Hodgkin Lymphoma
Peking University Cancer Hospital & Institute 42
Load More Results